These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7228495)

  • 21. Uses of fluorescent cholinergic analogues to study binding sites for cholinergic ligands in Torpedo californica acetylcholine receptor.
    Bode J; Moody T; Schimerlik M; Raftery M
    Biochemistry; 1979 May; 18(10):1855-61. PubMed ID: 435448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The activating effect of tetramethylammonium ions and acetylcholine on horse serum choline esterase].
    Brestkin AP; Brik IL
    Biokhimiia; 1967; 32(1):3-12. PubMed ID: 5591606
    [No Abstract]   [Full Text] [Related]  

  • 23. [A comparative study of the interaction of the cholinesterase from the brain of the cabbage fly, the acetylcholinesterase from bovine erythrocytes and the butyrylcholinesterase from horse blood serum with organophosphorus inhibitors].
    Grigor'eva GM; Krasnova TI; Khovanskikh AE
    Zh Evol Biokhim Fiziol; 1990; 26(2):145-50. PubMed ID: 2375193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of the plasma cholinesterase variants by pancuronium bromide and some of its analogues.
    Whittaker M; Britten JJ
    Clin Chim Acta; 1980 Nov; 108(1):89-94. PubMed ID: 6108807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetics of the inhibition of human serum cholinesterase phenotypes with the dimethylcarbamate of (2-hydroxy-5-phenylbenzyl)-trimethylammonium bromide (Ro 02-0683).
    Prester L; Simeon V
    Biochem Pharmacol; 1991 Nov; 42(12):2313-6. PubMed ID: 1764116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-(dimethylamino)naphthalene-1-sulfonic acid, a fluorescent probe of the medium chain fatty acid binding site of serum albumin.
    Doody MC; Gotto AM; Smith LC
    Biochemistry; 1982 Jan; 21(1):28-33. PubMed ID: 7059578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Active site kinetics of horse serum cholinesterase.
    Principato GB; Gabriella R; Virginia B; Elvio G
    Biochem Int; 1984 Jan; 8(1):135-41. PubMed ID: 6477593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Acetylcholinesterase. II. Experimental aspects of interaction with reversible effectors under conditions of high ionic strength].
    Désiré B; Blanchet G; Definod G; Arnaud R
    Biochimie; 1975; 57(11-12):1359-70. PubMed ID: 4154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Inhibition of cholinesterases by quaternary phosphonium compounds].
    Brestkin AP; Zhukovskiĭ IuG; Kolchanova NA; Mirzabaev EA; Rozengart EV
    Ukr Biokhim Zh (1978); 1986; 58(2):26-30. PubMed ID: 3705200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple binding of D-tubocurarine to acetylcholinesterase.
    Zorko M; Pavlic MR
    Biochem Pharmacol; 1986 Jul; 35(14):2287-96. PubMed ID: 3729986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A method for the kinetic analysis of progress curves using horse serum cholinesterase as a model case.
    Balcom JK; Fitch WM
    J Biol Chem; 1970 Apr; 245(7):1637-47. PubMed ID: 5461957
    [No Abstract]   [Full Text] [Related]  

  • 32. Aromatic amino-acid residues at the active and peripheral anionic sites control the binding of E2020 (Aricept) to cholinesterases.
    Saxena A; Fedorko JM; Vinayaka CR; Medhekar R; Radić Z; Taylor P; Lockridge O; Doctor BP
    Eur J Biochem; 2003 Nov; 270(22):4447-58. PubMed ID: 14622273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum cholinesterase inhibition by boronic acids.
    Garner CW; Little GH; Pelley JW
    Biochim Biophys Acta; 1984 Oct; 790(1):91-3. PubMed ID: 6477941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A gorge-spanning, high-affinity cholinesterase inhibitor to explore beta-amyloid plaques.
    Elsinghorst PW; Härtig W; Goldhammer S; Grosche J; Gütschow M
    Org Biomol Chem; 2009 Oct; 7(19):3940-6. PubMed ID: 19763296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The interaction of organosilicon bisammonium compounds with the cholinesterases of Far-Eastern squids and vertebrates. The comparative enzymological, kinetic and conformational aspects].
    Rozengart EV; Shestakova NN; Khovanskikh AE; Prokator SO; Kovalev NN; Epshteĭn LM
    Zh Evol Biokhim Fiziol; 1995; 31(5-6):546-55. PubMed ID: 8787143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxadiazolidinones: irreversible inhibition of cholinesterases and effects on acetylcholine receptors.
    Bakry NM; Sherby SM; Eldefrawi AT; Eldefrawi ME
    Neurotoxicology; 1986; 7(3):1-10. PubMed ID: 3822252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Competition between substrates for acetylcholinesterase and cholinesterase.
    Reiner E; Simeon V
    Biochim Biophys Acta; 1977 Jan; 480(1):137-42. PubMed ID: 831831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of cyclic and acyclic nicotinic cholinergic agonists using radioligand binding, single channel recording, and nuclear magnetic resonance spectroscopy.
    McGroddy KA; Carter AA; Tubbert MM; Oswald RE
    Biophys J; 1993 Feb; 64(2):325-38. PubMed ID: 8457664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of atypical and usual human serum cholinesterase. Purification, number of active sites, substrate affinity, and turnover number.
    Lockridge O; La Du BN
    J Biol Chem; 1978 Jan; 253(2):361-6. PubMed ID: 618874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Kinetics of hydrolysis of the phenyl analog of acetylcholine under the action of cholinesterase from horse serum and acetylcholinesterase from bovine erythrocytes].
    Brestkin AP; Brik IL; Teplov NE
    Biokhimiia; 1968; 33(5):1059-68. PubMed ID: 5703735
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.